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Abstract 
Acute pancreatitis is one of the most common causes of hospitalisation from gastrointestinal diseases. The 
causes of pancreatitis vary between countries. Acute pancreatitis is classified based on Revised Atlanta 
classification 2013 as mild, moderately severe and severe acute pancreatitis. Acute pancreatic severity can be 
stratified by scoring systems such as Ranson’s score, BISAP score, APACHE-II score, SOFA score. In severe 
acute pancreatitis, to diagnose, abdominal pain raised amylase or lipase, supported imaging finding and organ 
failure. Organ failure can be diagnosed by using Modified Marshall Scoring System. Management is started 
conservatively, which are fluid resuscitation, enteral nutrition, analgesics, and antibiotics. Surgical management is 
indicated when infected pancreas necrosis is detected. In this review, we will discuss the current management 
based on recent research. 
 
 
 
 
 
Introduction 
 
Acute pancreatitis is one of the most common 
causes of hospitalisation from gastrointestinal 
diseases, with a global incidence ranging from 5-30 
cases per 100,000 population per year. In America, 
pancreatitis causes more than 800,000 hospital visits 
and costs more than 2.6 billion dollars [1]. 
The causes of pancreatitis vary between 
countries. Alcohol is still the dominant disease in 
Western countries, while in Eastern countries, 
especially Asia, the most common cause is biliary 
disease (49-54%) [1], [2]. Others were caused by drug 
reactions, pancreatic and cystic malignancies, and 
hypertriglyceridemia [2]. 
 
 
Grading and Severity 
 
Revised Atlanta classification 2013 are 
commonly used to categorise acute pancreatitis, 
which is mild, moderately severe and severe acute 
pancreatitis. Most of the acute pancreatitis were mild, 
in which organ failure or complications were not 
found. In moderately severe acute pancreatitis, Organ 
failure was transiently found in less than 48 hours [3], 
[4], [5]. Meanwhile, in severe acute pancreatitis (SAP), 
organ failure was seen for more than 48 hours. 
Moderately severe and severe acute pancreatitis 
manifest in systemic and local complication. The 
systemic complication in moderately severe acute 
pancreatitis was seen in chronic renal failure patient 
who presents with acute symptoms. Local 
complications usually manifest in the pancreatic and 
peri-pancreatic fluid collection. Those collections 
generally appear in the late phase of pancreatitis [4]. 
Acute pancreatic severity is influenced by 
organ failure. Revised Atlanta recommend Modified 
Marshall scoring system as the main tool in 
determining organ failure [4]. Modified Marshall 
scoring system (Table 1) include respiratory, 
cardiovascular and renal systems score. Score more 
than 2 of any organs indicate organ failure. Acute 
pancreatic severity can be stratified by scoring 
systems such as Ranson’s score, BISAP score, 
APACHE-II score, SOFA score. Ranson’s criteria are 
used within 48 hours of the onset of the attack. 
APACHE-II score of 9 or more is considered as 
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severe pancreatitis. APACHE score can be observed 
during the course of acute pancreatitis. The disease is 
assumed as severe acute pancreatitis when the score 
is 3 or more. BISAP score is observed during the first 
24 hours of admission to predict mortality before the 
onset of organ failure. BISAP score of more than 3 is 
related to 5-20% mortality [5]. 
Table 1: Modified Marshall scoring system [4]  
ORGAN SYSTEM 0 1 2 3 4 
Respiratory PO/FiO2 (mmHg) > 300 226-300 151-225 76-150 ≤ 75 
Renal Serum creatinine (µmol/liter) ≤ 100 101-200 201-350 351-500 > 500 
Hepatic Serum bilirubin (µmol/liter) ≤ 20 21-60 61-120 121-240 > 240 
Cardiovascular PAR ≤ 10,0 10,1-15,0 15,1-20 20,1-30 > 30,0 
Hematologic Platelet / nl > 120 81-120 51-80 21-50 ≤ 20 
Neurologic Glassgow coma score 15 13-14 10-12 7-9 ≤ 6 
  
 
Diagnosis 
 
Revised Atlanta classification requires the 
presence of abdominal pain, the increment of amylase 
or lipase more than 3 times upper limit of the normal 
range, and supported radiographic findings. The 
abdominal pain characterised by epigastric pain, 
followed by nausea and vomiting. In physical 
examination, rebound tenderness, abdominal 
distention, Cullen’s sign, Grey Turner’s sign can be 
found. In severe condition, reduced bowel sound, 
hypotension can also be found. Pancreatic acinar cell 
leakage in interstitial space and absorption into 
circulation cause Increment in amylase and lipase [3], 
[4], [5].  Contrast-enhanced CT scan (CE-CT scan) is 
the standard radiographic imaging in detecting acute 
pancreatitis [3], [4], [5]. In severe acute pancreatitis, 
CE-CT scan can be used to find pancreatic gland 
necrosis and the local complications. Pancreatic gland 
necrosis completely appears in 4 days after the onset 
of SAP. Before that time, CE-CT scan cannot 
precisely detect pancreatic necrosis. Other 
radiographic modalities that were commonly used in 
diagnosing acute pancreatitis were ultrasonography, 
MRI. Ultrasonography has a limited role in diagnosing 
acute pancreatitis, especially in ileus patient. 
Abundant air volume in the intestine in ileus patient 
cause difficulty in the visualization of the pancreas. 
MRI is considered as a good alternative in detecting 
pancreatic necrosis, pancreatic collection and peri-
pancreatic collection. Magnetic resonance 
cholangiopancreatography (MRCP) can be used as 
an alternative to ERCP to evaluate pancreatic duct [4], 
[5].  
 
 
Management  
 
Fluid resuscitation 
In severe acute pancreatitis, the patient could 
have excessive vomiting, reduced oral intake, third 
space extravasation, respiratory losses, and 
diaphoresis. Therefore, fluid resuscitation becomes 
the most important step in managing severe acute 
pancreatitis [6]. It is recommended to be done as early 
as possible. Crystalloid is the preferred choice in 
resuscitation. There are many types of research 
(Table 2) showed Ringer Lactate as the replacement 
fluid has many beneficial effects. The solution has to 
be given 250-500 ml per hour in the first 12-24 hours. 
NaCl 0.9% is not recommended since it triggered 
hyperchloremic metabolic acidosis when it was given 
in a large volume [6].  
Table 2: The beneficial effect of Lactated Ringer’s solution in 
various research 
Author Journal, Year Method Conclusion 
De ‘Madaria 
et al., [7] 
United European 
Gastroenterology 
Journal, 2018 
RCT Lactated Ringer (LR) is associated with a 
reduction of CRP levels. LR has an anti-
inflammatory effect in patients with acute 
pancreatitis 
Iqbal et al. 
[8] 
Journal of 
Digestive 
Diseases, 2018 
Meta-
analysis 
LR has anti-inflammatory effects and is 
associated with decreased risk of persistent 
SIRS at 24h, which is a marker of severe 
disease in AP patients 
Choosakul 
et al. [9] 
Pancreatology, 
2018 
RCT LR solution was superior to NS in SIRS 
reduction in acute pancreatitis only in the first 
24h. But SIRS at 48h and mortality were not 
different between LR and NS. 
Wu et al. 
[10] 
Clinical 
Gastroenterology 
and Hepatology, 
2011 
RCT Patients with acute pancreatitis who were 
resuscitated with LR solution had reduced 
systemic inflammation compared with those 
who received saline. 
Abbreviations: RCT (Randomized control trial); CRP (C-reactive protein); SIRS (Systemic 
inflammatory response syndrome); LR (Lactated Ringer’s); NS (Normal saline). 
 
Few parameters can be used to predict the 
outcome after fluid resuscitation, which is hematocrit 
and BUN. Hemoconcentration, which can be seen 
from hematocrit, develop in the hypovolemic condition 
in SAP. Hematocrit < 44%-47% is a risk factor for 
developing necrosis in the pancreas [6] Wu et al., 
revealed that hemoconcentration was related to 
increment in mortality rate among hospital transferred 
patients. BUN was also recommended by Wu et al., 
as a predictor of pancreas necrosis. If fluid 
resuscitation had been done, BUN was not 
decreased, then the patient would have increased risk 
of pancreas necrosis [10].  
To monitor the responsiveness of 
resuscitation, beside BUN and hematocrit, the 
physician was recommended to monitor urine output. 
Urine output > 0.5 ml/kg BW/hour was suggested as 
the target. Lactate was also mentioned as the 
monitoring parameter. However, there is no evidence 
to apply this to severe acute pancreatitis [6].  
 
Enteral nutrition 
Enteral nutrition was recommended for severe 
acute pancreatitis over parenteral nutrition due to 
many beneficial effects as shown by few meta-
analysis and trial (Table 3). Enteral nutrition may 
maintain the function and structure of intestinal 
mucosa [5], [11]. Enteral nutrition was suggested to 
be given as early as 48 hours of admission [13], [11] 
Early enteral nutrition could reduce mortality, multiple 
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organ failure and infection in comparison with late 
enteral nutrition and parenteral nutrition [12]. 
Parenteral nutrition was previously recommended as 
early intervention since it reduces the stimulation of 
pancreas to secrete enzymes, but it can lead to 
intestinal atrophy and altered intestinal barrier. As 
consequences, microorganisms from the gut will 
translocate to the systemic circulation through 
damaged intestinal epithelial cells causing sepsis. 
Furthermore, toxic products and inflammatory 
mediators also translocate because of increased 
intestinal permeability in the early stage of severe 
acute pancreatitis [11]. 
Table 3: Comparison of Enteral Nutrition and Total Parenteral 
Nutrition 
Author Journal, Year Method Conclusion 
Qi et al. 
[14] 
Journal of 
Parenteral and 
Enteral 
Nutrition, 2018 
Meta-
analysis 
Comparing early EN to TPN showed a significant 
reduction in multiple organ failure and pancreatic 
related infections 
Vieira et 
al. [15] 
Acta Cirugica 
Brasileira, 2010 
RCT More complications occurred in the parenteral 
group, although the difference was not statistically 
significant. Infectious complications were 
significantly more frequent in the parenteral group 
(p = 0.006) 
Li et al. 
[16] 
Journal of 
International 
Medical 
Research, 
2018 
Meta-
analysis 
The duration of hospitalisation was significantly 
shorter in the EN than TPN group. Compared with 
TPN, EN had a lower risk of pancreatic infection 
and organ failure. 
Yi et al. 
[17] 
Internal 
Medicine, 2012 
Meta-
analysis 
TEN was significantly superior to TPN when 
considering mortality, infectious complications, 
organ failure 
Quan et 
al. [18] 
Clinical 
Gastroenterolo
gy and 
Hepatology, 
2011 
Meta-
analysis 
Compared with TPN, EN was associated with a 
significantly lower incidence of pancreatic infection 
complications, MOF, and mortality 
Abbreviations: RCT (randomized control trial), EN(enteral nutrition), TPN(total parenteral 
nutrition, MOF(multiple organ failure), TEN(Total Enteral nutrition). 
 
In a comparison of nasogastric and 
nasojejunal feeding, many trials and meta-analysis 
(Table 4) showed no significant difference in mortality, 
complications and length of stay [19]. Nasogastric 
feeding was cheaper, easy to apply and simpler. 
Meanwhile, Nasojejunal feeding has to be done by 
interventional radiologist or endoscopy operator 
causing a delay in feeding and increment of cost. 
Table 4: Comparison of Nasogastric Feeding and Nasojejunal 
Feeding 
Author Journal, Year Method Conclusion 
Zhu et al. 
[20] 
Gastroenterolo
gy Research 
and Practice, 
2016 
RCT There were no significant differences in the 
incidences of mortality, infectious complications, 
digestive complications, or length of hospital stay 
between NG and NJ nutrition groups. NG nutrition 
was as safe and effective as NJ nutrition in with 
SAP 
Chang et 
al. [21] 
Critical Care 
2013 
Meta-
analysis 
There were no significant differences in the 
incidences of mortality between NGT and NJT 
groups. NG feeding is safe and well-tolerated 
compared with NJ feeding 
Singh et 
al. [22] 
Pancreas 2012 RCT Early enteral feeding through NG was not inferior to 
NJ in patients with SAP. Infection complications and 
length of hospital stay were comparable in both 
groups. 
Kumar et 
al. [23] 
Journal of 
Clinical 
Gastroenterolo
gy, 2006 
RCT Enteral nutrition at a slow infusion is well tolerated 
by both NJ and NG routes in patients with SAP. 
Neither NJ nor NG feeding leads to recurrence or 
worsening of pain in SAP 
Eatock et 
al. [24] 
American 
Journal of 
Gastroenterolo
gy, 2005 
RCT The simpler, cheaper, and more easily used NG 
feeding is as good as NJ feeding in patients with 
objectively graded severe AP 
Abbreviations: RCT (randomized control trial); NGT (nasogastric tube); NJ (naso-jejunal); 
AP (acute pancreatitis). 
 
 
Antibiotics 
Many researchers conclude that antibiotics 
were recommended to be given in severe acute 
pancreatitis patients who developed sepsis, 
pancreatic or extrapancreatic infection, infected 
necrosis systemic inflammatory response [25]. 
Antibiotic as prophylaxis does not decrease mortality 
and secondary infection significantly [5], [13]. It is 
given as prophylaxis when infection marker, such as 
procalcitonin, IL-6, is detected [25]. The 
recommended antibiotics in treating severe acute 
pancreatitis that covers gram-positive (Clostridium) 
and gram-negative (E. coli, Klebsiella, Pseudomonas, 
Proteus) as well as anaerobes such as imipenem, 
meropenem, ciprofloxacin, clindamycin and metro-
nidazole [13], [25]. All these antibiotics have adequate 
penetration and bactericidal effect in infected 
pancreatic necrosis. Prolong use of antibiotics have a 
risk of multi drugs resistance and development of 
fungal infection which is related to a long hospital stay 
and poor outcome [5], [25].  
 
Analgesics 
Pain is one of the most complained problems 
of acute pancreatitis patients. Therefore, pain 
management needs to be given in the first 24 hours to 
maintain the patient’s quality of life. There are many 
choices of analgesics, such as fentanyl, meperidine, 
non-steroid anti-inflammatory drugs. Pain 
management was based on WHO analgesic ladder 
which consist of 4 steps (Step 1: NSAID, Step 2: low 
potent opioid ± NSAID ± adjuvant drugs, Step 3: High 
potent opioid ± NSAID ± adjuvant drugs, Step 4: 
interventional treatment ± high potent opioid ± NSAID 
± adjuvant drugs) [27]. Opioids had been reported in 
the past study as a trigger of spasm of the sphincter of 
Oddi but in a recent Cochrane review on five RCTs 
with a total of 227 patients showed no difference 
between opioids and other analgesic options 
regarding the risk of complications or clinically serious 
adverse events [26]. A meta-analysis that was made 
by Stigliano et al. concluded there was no credible 
evidence to avoid the use of morphine in managing 
pain in acute pancreatitis [28].  
 
Somatostatin and octreotide 
Somatostatin and its long-acting analogue 
octreotide are the inhibitors of exocrine pancreatic 
secretion and further prevent the release and 
activation of enzymes. The benefit of these medica-
tions is controversial. W Uhl et al. revealed that 
octreotide had no benefit in the treatment of acute 
pancreatitis [29]. However, Paran et al., showed that 
in their study, complication rate was lower in treatment 
group than in control group (sepsis [24% vs 76%, p < 
0.0002], ARDS [28% vs 56%, p = 0.04]). Therefore, 
they suggested that octreotide might have benefit in 
the treatment of severe acute pancreatitis [30].  
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Surgical management 
Surgical interventions are indicated when 
infected necrosis and gallstone obstruction causing 
biliary pancreatitis is detected. Delayed surgical 
intervention was suggested because it was related to 
lower incidences of multi-organ failure, uncontrolled 
bleeding and sepsis. Therefore, the recommendation 
is to delay the surgical intervention until the infected 
necrosis process stops expanding and by the time, 
the necrotic tissue will liquify. After it liquefies, 
percutaneous or endoscopic drainage of the infected 
collection can be ordered. Because of open 
necrosectomy was associated with high morbidity and 
mortality, minimally invasive surgical techniques are 
preferred as the next step of the Step-up approach if 
drainage by endoscopy failed [4]. Step up approach 
which was started with minimal invasive drainage 
technique and endoscopic necrosectomy, was 
concluded by Rasch et al. had significant decrement 
of morbidity and mortality in necrotising pancreatitis 
compared to primarily surgical intervention [31]. 
 
 
Conclusion 
 
Severe acute pancreatitis is treated 
conservatively by fluid resuscitation, early enteral 
feeding, analgesic, and antibiotic. Ringer lactate is the 
recommended fluid resuscitation. Enteral feeding as 
early as 48 hours after admission is the recommended 
protocol. When dealing with pain, non-opioid and 
opioid can be used in severe acute pancreatitis. 
Antibiotics are indicated when infection markers are 
detected. Somatostatin and it's analogue show no 
benefit in the treatment of severe acute pancreatitis.  
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